Seems interesting previous guy was based in Us and it appeasrs so is Mr Sahm Nasseri. No mention of wether he will be moving to Australia, looks like he is fairly well settled in Usa though. I wonder if they want someone to represent pyc to these behemoths in Usa who just might stump up large amounts of cash of they like something. Im still shocked at the size of kite buyout, although it seems they are on the verge of getting approval from fda for one of their Cart drugs.
Exerpt From cen.acs.org/articles/95/i35/Gilead-acquire-Kite-Pharma-119.html
"Kite is a leader in the emerging field of cell therapy, in which a person’s immune cells are activated to fight cancer. Its top drug candidate, axicabtagene ciloleucel (Axi-cel), is a chimeric antigen receptor T-cell (CART) therapy currently under priority review by the U.S. Food & Drug Administration.
Axi-cel is expected to be the first treatment approved for refractory aggressive non-Hodgkin’s lymphoma. Just two days after Gilead announced the deal, FDA approved its first CART therapy—Novartis’s Kymriah—for a form of leukemia."
If only we could get FDA approval for first myc inhibitor??? Loooonnng way off still but who knows if someone decides it has promise.
PYC Price at posting:
3.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)